​

Lipella Pharmaceuticals (LIPO) Revenue & Revenue Breakdown

OverviewForecastFinancialsChart

Lipella Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$449.62M

Latest Revenue (Q)

$80.38M

Main Segment (Y)

Grant Revenues

Lipella Pharmaceuticals Revenue by Period

Lipella Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$449.62M244050.07%
2022-12-31$184.16K-28.99%
2021-12-31$259.35K-73.03%
2020-12-31$961.68K38.42%
2019-12-31$694.75K-

Lipella Pharmaceuticals generated $449.62M in revenue during NA 2023, up 244050.07% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Lipella Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$80.38M-41.08%
2024-06-30$136.43M93422.76%
2024-03-31$145.88K20.72%
2023-12-31$120.84K-99.88%
2023-09-30$104.05M-2.46%
2023-06-30$106.68M90266.63%
2023-03-31$118.05K-21.83%
2022-12-31$151.01K100.00%
2022-09-30-100.00%
2022-06-30--100.00%
2022-03-31$33.15K28.08%
2021-12-31$25.88K100.00%
2021-09-30--100.00%
2021-06-30$148.97K76.30%
2021-03-31$84.50K-

Lipella Pharmaceuticals generated $80.38M in revenue during Q3 2024, up -41.08% compared to the previous quarter, and up 75.35% compared to the same period a year ago.

Lipella Pharmaceuticals Revenue Breakdown

Lipella Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22
Grant Revenues$184.16K

Lipella Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 22: Grant Revenues (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 23Mar 23
Grant Revenues$104.05K$118.05K

Lipella Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Grant Revenues (100.00%).

Lipella Pharmaceuticals Revenue Breakdown by Country

Quarterly Revenue by Country

CountryMar 23
Grant Revenues$118.05K

Lipella Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Mar 23: Grant Revenues (100.00%).

Lipella Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
LIPOLipella Pharmaceuticals$449.62M$80.38M
FENCFennec Pharmaceuticals$21.64M$6.97M
ICCCImmuCell$17.47M$6.01B
SNTISenti Biosciences$2.56M-
INBXInhibrx Biosciences$1.80M-
ANEBAnebulo Pharmaceuticals--
ACRVAcrivon Therapeutics--
CELCCelcuity--
MNPRMonopar Therapeutics--
PTIXProtagenic Therapeutics-$50.29K
ELVNEnliven Therapeutics--

LIPO Revenue FAQ

What is Lipella Pharmaceuticals’s yearly revenue?

Lipella Pharmaceuticals's yearly revenue for 2023 was $449.62M, representing an increase of 244050.07% compared to 2022. The company's yearly revenue for 2022 was $184.16K, representing a decrease of -28.99% compared to 2021. LIPO's yearly revenue for 2021 was $259.35K, representing a decrease of -73.03% compared to 2020.

What is Lipella Pharmaceuticals’s quarterly revenue?

Lipella Pharmaceuticals's quarterly revenue for Q3 2024 was $80.38M, a -41.08% decrease from the previous quarter (Q2 2024), and a -22.75% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $136.43M, a 93422.76% increase from the previous quarter (Q1 2024), and a 27.89% increase year-over-year (Q2 2023). LIPO's quarterly revenue for Q1 2024 was $145.88K, a 20.72% increase from the previous quarter (Q4 2023), and a 23.58% increase year-over-year (Q1 2023).

What is Lipella Pharmaceuticals’s revenue growth rate?

Lipella Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 173265.03%, and for the last 5 years (2019-2023) was 64616.56%.

What are Lipella Pharmaceuticals’s revenue streams?

Lipella Pharmaceuticals's revenue streams in c 22 are Grant Revenues

What is Lipella Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Lipella Pharmaceuticals was Grant Revenues. This segment made a revenue of $184.16K, representing 100.00% of the company's total revenue.